Jabra Enhance Select M3 vs Otofonix Groove

The Jabra Enhance Select M3 is a premium OTC hearing aid priced at $1,995, earning an A grade with a SoundScore of 4.0/5 in our lab testing. This behind-the-ear device delivers strong overall performance, positioning it among the better-performing options in the OTC category. In our testing, the Enhance Select M3 showed notable strengths in speech clarity during quiet environments, scoring 3.8/5—a solid result that sits 0.95 points above the OTC category average. Music streaming quality also performs well at 2.8/5, which is 0.87 points above average for the category, though still mixed in absolute terms. Feedback handling is excellent at 4.6/5, ensuring stable performance during movement and daily activities. The device does show limitations in challenging listening environments. Speech in noise scored 1.3/5, which falls 0.18 points below the category average and represents a low absolute score. Users who frequently encounter noisy restaurants, busy social gatherings, or similar environments may find this a meaningful limitation. Own-voice comfort scored 2.7/5—above the category average by 0.18 points but only mixed in absolute terms. Consumers seeking strong performance in quieter settings with good music streaming capability may find the Enhance Select M3 appealing. However, shoppers should note that alternatives like the Sennheiser All Day Clear and Jabra Enhance Pro 20 at Costco offer comparable or higher scores at lower price points, potentially representing better overall value for budget-conscious buyers.

The Otofonix Groove is a behind-the-ear prescription hearing aid priced at $795, earning a C grade with a SoundScore of 2.7/5 in our lab testing. This rechargeable BTE ranks #38 of 39 devices in the prescription hearing aid category, placing it in the bottom 5% of its class. In our testing, the Groove demonstrated excellent feedback handling at 5.0/5, scoring 0.28 points above the category average. This represents a genuine strength, with the device maintaining stability during our standardized challenge motions. However, speech performance was significantly limited, with speech in quiet scoring 1.0/5 (2.40 points below the category average of 3.40) and speech in noise also at 1.0/5 (1.11 points below average). Music streaming was not functional in our tests, scoring 0.0/5 against a category average of 2.76. Own-voice comfort also fell well below typical prescription hearing aid performance at 0.4/5, which is 2.30 points below the category average. At this price point, several lower-cost alternatives delivered stronger overall performance in our testing. Consumers seeking value in the prescription category may want to explore other options, though those requiring robust feedback control in a rechargeable BTE format may find the Groove's stability noteworthy despite its other limitations.